In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Neurocrine Biosciences, Inc.. Trade Record

NASDAQ:NBIX Neurocrine Biosciences, Inc. stock gains 16.22% Exit Jun 22, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart NBIX May 10, 2018, priceSeries
About Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States and internationally. The company's lead products include INGREZZA (valbenazine), a vesicular monoamine transporter 2 inhibitor (VMAT2) used for the treatment of movement disorders; elagolix, a gonadotropin-releasing hormone (GnRH) antagonist that is in Phase III clinical trials used for women's health; and opicapone, a catechol-O-methyltransferase inhibitor, which is in Phase III clinical trials used for in adjunct therapy and preparations of levodopa/DOPA decarboxylase inhibitors for adult patients with Parkinson's disease. It is also developing NBI-640756 that is in Phase I clinical trials used for the treatment of essential tremor; and NBI-74788, which is in Phase I clinical trials used for the treatment of classic congenital adrenal hyperplasia. In addition, the company's research programs comprise VMAT2 Inhibitors for movement disorders, bipolar disorders, and schizophrenia; and G Protein-Coupled Receptors and Ion Channels for epilepsy, essential tremor, pain, and other Indications. It has collaborations with AbbVie Inc. to develop and commercialize elagolix and GnRH antagonists for women's and men's health; Mitsubishi Tanabe Pharma Corporation to develop and commercialize INGREZZA for movement disorders; and BIAL Portela & Ca, S.A. to develop and commercialize opicapone for the treatment of human diseases and conditions, including Parkinson's disease. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
95.96
Entry Date
May 10, 2018
Entry Price
87.83
Sell Date
Jun 22, 2018
Sell Price
102.07
Net Gain
16.22%
Hold Time
30 Trading Days